(0.51%) 5 154.04 points
(0.39%) 38 825 points
(0.52%) 16 241 points
(0.86%) $78.78
(3.69%) $2.22
(1.04%) $2 332.50
(3.62%) $27.66
(0.88%) $973.80
(-0.16%) $0.927
(-0.62%) $10.81
(-0.31%) $0.795
(-0.50%) $90.99
2 days till quarter result
(amc 2024-05-08)
Expected move: +/- 11.84%
7.50% $ 0.860
Live Chart Being Loaded With Signals
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain...
Stats | |
---|---|
Volumen de hoy | 240 995 |
Volumen promedio | 138 824 |
Capitalización de mercado | 14.58M |
EPS | $0 ( 2024-04-04 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.313 |
ATR14 | $0.0740 (8.03%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-15 | Nantahala Capital Management, Llc | Buy | 0 | Common Stock |
2023-07-20 | Nantahala Capital Management, Llc | Buy | 2 205 883 | 2023 Series A Warrants |
2023-07-20 | Nantahala Capital Management, Llc | Buy | 2 205 883 | 2023 Series B Warrants |
2023-07-20 | Nantahala Capital Management, Llc | Buy | 750 883 | 2023 Pre-Funded Warrants |
2024-03-15 | Nantahala Capital Management, Llc | Buy | 755 000 | Call Option (Right to Buy) |
INSIDER POWER |
---|
82.70 |
Last 92 transactions |
Buy: 3 436 001 | Sell: 171 828 |
Volumen Correlación
AcelRx Pharmaceuticals Correlación
10 Correlaciones Más Positivas | |
---|---|
NAKD | 0.974 |
TNGX | 0.964 |
UTHR | 0.952 |
IMV | 0.941 |
WTBA | 0.94 |
AVIR | 0.939 |
UK | 0.937 |
APM | 0.936 |
BFRI | 0.935 |
GRNA | 0.934 |
10 Correlaciones Más Negativas | |
---|---|
IDCC | -0.956 |
ALTR | -0.956 |
PDFS | -0.956 |
ANSS | -0.954 |
LPTH | -0.953 |
APXI | -0.952 |
SJ | -0.952 |
SLMBP | -0.952 |
NCAC | -0.951 |
DHCAU | -0.95 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
AcelRx Pharmaceuticals Correlación - Moneda/Commodity
AcelRx Pharmaceuticals Finanzas
Annual | 2023 |
Ingresos: | $651 000 |
Beneficio Bruto: | $651 000 (100.00 %) |
EPS: | $-0.000700 |
FY | 2023 |
Ingresos: | $651 000 |
Beneficio Bruto: | $651 000 (100.00 %) |
EPS: | $-0.000700 |
FY | 2022 |
Ingresos: | $1.77M |
Beneficio Bruto: | $-820 000 (-46.30 %) |
EPS: | $5.73 |
FY | 2021 |
Ingresos: | $2.82M |
Beneficio Bruto: | $-935 000 (-33.18 %) |
EPS: | $-5.86 |
Financial Reports:
No articles found.
AcelRx Pharmaceuticals
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain; ARX-02, which is in Phase 2 clinical trial for the treatment of cancer breakthrough pain in opioid-tolerant patients; and 4ARX-03 for mild sedation and pain relief during painful procedures. Its product candidates also include Niyad, a regional anticoagulant for the extracorporeal circuit; and LTX-608, a nafamostat formulation for direct IV infusion being explored as an investigational product for antiviral treatment of COVID, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is based in Hayward, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico